Choose your language:
Facebook
LinkedIn
Twitter
Providing Capital & Management Solutions for Private & Public Companies and Sophisticated Investors

Haixi Pharmaceutical International Holdings Limited IPO

BlueMount Capital is pleased to announce that the Initial Public Offer for Haixi Pharmaceutical International Holdings Limited has opened for investors.

Haixi Pharmaceuticals Prospectus

Key IPO Details

  • Substantial increasing profits and assets with high margins
  • First Chinese pharmaceutical company  to be listed on the ASX
  • Long-standing brand recognition with 20 years history
  • High dividend payout ratio planned at 50% of NPAT, payable twice a year
  • Value investment at a P/E lower than sector average on ASX and HKEX
  • Plans to expand into the Australian market and intends to acquire or invest in Australian companies in the pharmaceutical sector
  • ​China is the worlds second largest market for pharmaceuticals

The Prospectus for the offer and a Company Presentation can be obtained via:

www.bluemountcapital.com/HXP

Open Date:  21 July 2017

Close Date: 27 October 2017

Minimum Investment A$ 2,000